Molecular Partners Ag (MOLN) Price to FCF (2021 - 2026)
Molecular Partners Ag's (MOLN) quarterly Price to FCF came in at 4.94 in Q2 2026, down 16.25% year-over-year from 5.89 in Q2 2025, and up 99.94% quarter-over-quarter from 8810.4 in Q1 2026.
Analysis
Molecular Partners Ag (MOLN) Price to FCF (2021 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Price to FCF for 6 consecutive years, with 4.94 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to FCF fell 16.25% year-over-year to 4.94 in Q2 2026; TTM through Jun 2026 was 2.7, a 15.28% decrease from a year earlier, with the FY2025 full-year figure at 2.89, changed 0.25% from the prior year.
- Price to FCF was 4.94 for Q2 2026 at Molecular Partners Ag, up from 8810.4 in the prior quarter.
- Over five years, Price to FCF peaked at 1269.86 in Q1 2024 and troughed at 8810.4 in Q1 2026.
- A 5-year average of 591.53 and a median of 9.33 in 2023 frame the typical range for Price to FCF.
- Across the five-year window, Price to FCF jumped 10495.41% in 2024 and slumped 2796.37% in 2026, its largest moves.
- Over 5 years, Price to FCF stood at 1.91 in 2022, then tumbled by 549.49% to 8.59 in 2023, then tumbled by 49.64% to 12.86 in 2024, then rose by 0.64% to 12.77 in 2025, then jumped by 61.36% to 4.94 in 2026.
- The last three Price to FCF figures came in at 4.94 (Q2 2026), 8810.4 (Q1 2026), and 12.77 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Molecular Partners Ag | 156.54 Mn | 156.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.94 |
| Mar 31, 2026 | -8,810.40 |
| Dec 31, 2025 | -12.77 |
| Sep 30, 2025 | -12.11 |
| Jun 30, 2025 | -4.25 |
| Mar 31, 2025 | 326.75 |
| Dec 31, 2024 | -12.86 |
| Sep 30, 2024 | -12.30 |
| Jun 30, 2024 | -7.30 |
| Mar 31, 2024 | 1,269.86 |
| Dec 31, 2023 | -8.59 |
| Sep 30, 2023 | -10.06 |
| Jun 30, 2023 | -15.32 |
| Mar 31, 2023 | -12.22 |
| Dec 31, 2022 | 1.91 |
| Sep 30, 2022 | -1.38 |
| Jun 30, 2022 | 1.39 |
| Mar 31, 2022 | -3,322.87 |
| Dec 31, 2021 | -6.30 |
| Sep 30, 2021 | 9.82 |